Efficacy and safety of ‘Second Adjuvant’ therapy with BRAF/MEK inhibitors after local therapy for recurrent melanoma following adjuvant PD-1 based immunotherapy
Year: 2024
Type: article
Study design: Observational Study
Authors: Taylor, Amelia M, McKeown, Janet, Dimitriou, Florentia; https://orcid.org/0000-0003-4529-3372, Jacques, Sarah K, Zimmer, Lisa, Allayous, Clara, Yeoh, Hui-Ling, Haydon, Andrew, Ressler, Julia M, Galea, Claire, Woodford, Rachel, Kahler, Katharina, Hauschild, Axel, Festino, Lucia, Hoeller, Christoph, Schwarze, Julia K, Neyns, Bart, Wicky, Alexandre, Michielin, Olivier, Placzke, Joanna, Rutkowski, Piotr, Johnson, Douglas B, Lebbe, Celeste, Dummer, Reinhard, Ascierto, Paolo A, Lo, Serigne, Long, Georgina V, Carlino, Matteo S, Menzies, Alexander M
Language: English
Topic: Melanoma and MAPK Pathways
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7211993714